| Financial Year |
March 31 2023 |
| Monetary Funds |
1,581,409,516.51 |
| Held-for-trading Financial Assets |
23,500,000.00 |
| Notes Receivable |
37,749,693.19 |
| Accounts Receivable |
1,375,862,915.35 |
| Advances to Suppliers |
118,820,313.28 |
| Other Receivables |
39,722,909.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,165,097,343.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
41,729,888.37 |
| Total Current Assets |
4,639,536,665.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
110,221,172.24 |
| Investment Properties |
-- |
| Fixed Assetes |
3,421,900,974.28 |
| Under-construction Projects |
462,730,216.01 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
135,708,122.31 |
| R&D expenses |
-- |
| Goodwill |
302,284,415.05 |
| Long-Term Deferred and Prepaid Expenses |
121,125,381.05 |
| Deferred Income Tax Assets |
6,907,017.22 |
| Other Non-Current Assets |
698,279,784.08 |
| Sub-Total of Non-Current Assets |
5,801,780,375.09 |
| Total Assets |
10,441,317,041.00 |
| Short-Term Loans |
651,319,403.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
352,618,206.67 |
| Accounts Payable |
1,159,844,809.52 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
63,525,378.43 |
| Taxes Payable |
44,615,725.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,309,085.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
102,023,835.64 |
| Other Current Liabilities |
1,803,423.82 |
| Sub-Total of Current Liabilities |
2,442,600,898.02 |
| Long-term Loans |
450,296,250.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
201,877,963.47 |
| Other Non-Current Liabilities |
319,316,563.00 |
| Sub-Total of Non-Current Liabilities |
1,254,429,383.30 |
| Total Liabilities |
3,697,030,281.32 |
| Paid-In Capital(Or Share Stock) |
512,772,787.00 |
| Capital Surplus |
2,589,023,687.74 |
| Surplus Reserve |
256,386,393.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,953,346,502.72 |
| Minority Stockholder's Interest |
409,611,924.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,334,674,834.84 |
| Owner's Equity（Stockholder's Equity） |
6,744,286,759.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,441,317,041.00 |
